Articles
Biologics and biosimilars in Brazil – the strategic questions
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
Click below to access the full chapter.
Back
Share:
Last related news
February 14, 2022
Life sciences patent eligibility in Latin America: a guide
Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that … Life sciences patent eligibility in Latin America: a guide
October 22, 2021
Global Patent Litigation 2022 – Brazil
Our partners Claudio Barbosa and Rafael Lacaz Amaral authored a chapter about Brazil, first appeared in Global Patent Litigation Guide: Helping businesses navigate … Global Patent Litigation 2022 – Brazil
August 17, 2021
Privacy in Brazil 2021
The Q&A guide gives a high-level overview of privacy rules and principles, including what national laws regulate the right to respect for … Privacy in Brazil 2021